FloLipid Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with FloLipid
L
- L Thyroxine Roche (levothyroxine)
- lamivudine / zidovudine
- lansoprazole
- lansoprazole / naproxen
- lapatinib
- Larodopa (levodopa)
- larotrectinib
- Leader Heartburn Relief (cimetidine)
- ledipasvir / sofosbuvir
- lefamulin
- leflunomide
- lenacapavir
- lenalidomide
- leniolisib
- Lescol (fluvastatin)
- Lescol XL (fluvastatin)
- lesinurad
- letermovir
- letrozole / ribociclib
- levamlodipine
- Levo-T (levothyroxine)
- levodopa
- levoketoconazole
- Levolet (levothyroxine)
- Levotabs (levothyroxine)
- Levotec (levothyroxine)
- Levothroid (levothyroxine)
- Levothyrox (levothyroxine)
- levothyroxine
- levothyroxine / liothyronine
- Levoxyl (levothyroxine)
- Lexiva (fosamprenavir)
- Likmez (metronidazole)
- linezolid
- liothyronine
- liotrix
- Lipidil EZ (fenofibrate)
- Lipidil Micro (fenofibrate)
- Lipidil Supra (fenofibrate)
- Lipitor (atorvastatin)
- Lipofen (fenofibrate)
- Liptruzet (atorvastatin / ezetimibe)
- Livalo (pitavastatin)
- Livmarli (maralixibat)
- Locholest (cholestyramine)
- Locholest Light (cholestyramine)
- Lodoco (colchicine)
- Lofibra (fenofibrate)
- lomitapide
- lonafarnib
- lonapegsomatropin
- Lopid (gemfibrozil)
- lopinavir / ritonavir
- Lorbrena (lorlatinib)
- lorlatinib
- Lotrel (amlodipine / benazepril)
- lovastatin
- lovastatin / niacin
- Lumakras (sotorasib)
- Lunsumio (mosunetuzumab)
- Lupkynis (voclosporin)
- lusutrombopag
- Luvox (fluvoxamine)
- Luvox CR (fluvoxamine)
- Lynparza (olaparib)
- Lypqozet (atorvastatin / ezetimibe)
- Lysodren (mitotane)
More about FloLipid (simvastatin)
- FloLipid consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Latest FDA alerts (9)
- Side effects
- Dosage information
- During pregnancy
- Drug class: statins
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.